BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/27/2019 10:40:37 AM | Browse: 678 | Download: 911
 |
Received |
|
2019-03-12 01:57 |
|
Peer-Review Started |
|
2019-03-12 03:39 |
|
To Make the First Decision |
|
2019-04-02 02:40 |
|
Return for Revision |
|
2019-04-10 07:48 |
|
Revised |
|
2019-06-07 08:24 |
|
Second Decision |
|
2019-06-14 08:55 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2019-06-18 04:36 |
|
Articles in Press |
|
2019-06-18 04:36 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2019-06-21 03:36 |
|
Typeset the Manuscript |
|
2019-06-27 08:23 |
|
Publish the Manuscript Online |
|
2019-06-27 10:40 |
| ISSN |
1948-5182 (online) |
| Open Access |
This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Validation of modified albumin-bilirubin-TNM score as prognostic model to evaluate patients with hepatocellular carcinoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Omar Elshaarawy, Alzhraa Alkhatib, Mostafa Elhelbawy, Asmaa Gomaa, Naglaa Allam, Ayman Alsebaey, Eman Rewisha and Imam Waked |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Omar Elshaarawy, MBChB, MSc, Academic Fellow, Assistant Lecturer, Attending Doctor, Senior Research Fellow, Departemnt of Hepatology, Gastroenterology and Liver Transplantation, National Liver Institute, Menoufia University, Meleg Road, Menoufia 3511, Egypt. oelshaarawy@liver.menofia.edu.eg |
| Key Words |
Staging; Hepatocellular carcinoma; Albumin-Bilirubin grade; Scores |
| Core Tip |
In this study, we validate the modified version of the albumin-bilirubin-TNM grade (mALBI-T) in a retrospective Egyptian cohort. In addition, this study offers a comparative analysis of 8 different established and novel scoring systems. We concluded that the modified ALBI-T score is superior to the other scoring systems and offers a better prognostic tool. |
| Publish Date |
2019-06-27 10:40 |
| Citation |
Elshaarawy O, Alkhatieb A, Elhelbawy M, Gomaa A, Allam N, Alsebaey A, Rewisha E, Waked I. Validation of modified albumin-bilirubin-TNM score as prognostic model to evaluate patients with hepatocellular carcinoma. World J Hepatol 2019; 11(6): 542-552 |
| URL |
https://www.wjgnet.com/1948-5182/full/v11/i6/542.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v11.i6.542 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
